Universidad Católica San Antonio de Murcia   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Guadalupe Spain (1996)

Organization Overview

First Clinical Trial
2013
NCT01802112
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Catholic University of Murcia | Catholic University of Murcia (UCAM) | Francisco Javier Martínez Noguera | Iñigo Fernández de Luco Santamaría | Javier Hidalgo Tallón | San Antonio Technologies - San Antonio Catholic University of Murcia | San Antonio Technologies S.L. | UCAM | UCAM (Universidad Catolica San Antonio de Murcia) | UCAM University of Murcia | Universidad Católica de Murcia (UCAM) | Universidad Católica San Antonio de Murcia | Universidad Católica San Antonio de Murcia (UCAM) | Universidad Católica San Antonio de Murcia (UCAM). MiBioPath Group.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Overweight (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 32
  • # of Trial APIs: 31